Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07631923
What this trial is testing

Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+1 more
Shirley Ryan AbilityLab 35
Testing effectiveness (Phase 2)Study completedNCT00220779
What this trial is testing

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Grifols Therapeutics LLC 128
Not applicableTemporarily pausedNCT05949580
What this trial is testing

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Hoffmann-La Roche 500
Not applicableStudy completedNCT03758820
What this trial is testing

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueCognitive Therapy
Réseau Sep Idf Ouest 105
Large-scale testing (Phase 3)Study completedNCT02939079
What this trial is testing

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Isfahan University of Medical Sciences 50
Not applicableStudy completedNCT03768648
What this trial is testing

Cognition and MRI Markers in MS Patients With Aubagio® Treatment

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Bordeaux 75
Post-approval studies (Phase 4)Study completedNCT01142466
What this trial is testing

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 30
Not applicableStudy completedNCT04448977
What this trial is testing

Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Kessler Foundation 24
Not applicableActive Not RecruitingNCT05327322
What this trial is testing

Functional Outcomes From Diets in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
University of Alabama at Birmingham 100
Not applicableActive Not RecruitingNCT04009005
What this trial is testing

Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
Terry L. Wahls 44
Testing effectiveness (Phase 2)Study completedNCT01185821
What this trial is testing

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT04002934
What this trial is testing

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Riley Bove, MD 63
Testing effectiveness (Phase 2)WithdrawnNCT04880577
What this trial is testing

Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingFatigue
Massachusetts General Hospital
Not applicableStudy completedNCT03825601
What this trial is testing

PET with [18F]Flumazenil As an Index of Neurodegeneration in MS

Who this might be right for
Multiple SclerosisRelapsing-Remitting Multiple Sclerosis
Institut National de la Santé Et de la Recherche Médicale, France 45
Large-scale testing (Phase 3)Study completedNCT05028634
What this trial is testing

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Celgene 63
Not applicableLooking for participantsNCT06663111
What this trial is testing

Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Haukeland University Hospital 60
Not applicableUnknownNCT05496881
What this trial is testing

Exercise Effects in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive+2 more
University of Regina 69
Very early researchUnknownNCT06039007
What this trial is testing

A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ospedale Policlinico San Martino 24
Early research (Phase 1)Study completedNCT00076934
What this trial is testing

Safety of RG2077 in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Next Page